Our client sought to monetize its know-how in a proprietary medical technology but quickly recognized there were hundreds of potential applications for its technology. The client’s leadership team was split on which priorities to pursue and enlisted Bush Consulting Group to systematically and objectively prioritize its focus.  

Bush Consulting Group concluded that among 400-plus applications, only a few offered technical feasibility and had the potential to generate $200+ million in expected economic value, the threshold established by client leadership. This value creation insight led our client to develop products for the drug delivery market.  

The benefit of this clear path forward was apparent almost immediately. Our team facilitated partnership discussions between the client and a $40B medical products company. A deal was signed within 18 months.